Saad Mark E Insider Trading Activity

Average Profitability
23.86%
Insider Buys Quantity
18
Insider Buys Sum
$570,584.20
Insider Sells Quantity
1
Insider Sells Sum
$1.01M

Insider Activity of Saad Mark E

According to the SEC Form 4 filings, Saad Mark E, being in a position of

  1. director at Axsome Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 31346 shares for $5.18M,
    over all time since 2019-05-23, has bought 6800 shares for $192,077, and sold 51489 shares for $7.33M.

Biography of Saad Mark E

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,177,7321100

Comparison of Insiders on Amount of Buys and Sells

2025-12-31SaleAxsome Therapeutics, Inc.
AXSM
director
31,346
0.069%
$165.18$5.18M+3.48%
2025-09-05SaleAxsome Therapeutics, Inc.
AXSM
director
9,127
0.0183%
$125.07$1.14M+42.93%
2024-09-11SaleAxsome Therapeutics, Inc.
AXSM
director
11,016
0.0226%
$91.31$1.01M+14.18%
2021-11-17PurchaseAxsome Therapeutics, Inc.
AXSM
director
3,300
0.0087%
$34.52$113,922+7%
2019-05-23PurchaseAxsome Therapeutics, Inc.
AXSM
director
3,500
0.0098%
$22.33$78,155+40.71%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.